New Owner, Less Turnover
PRA Growing, in Flux
The large CRO recently moved its headquarters and went from public to private.
By appearances, the services offered by 1,000-employee Omnicare CR are identical to those performed by any large or mid-sized contract research organization (CRO). Omnicare handles the same standard therapeutic areas, the same typical functional areas of work such as trial setup, project management, monitoring and SAS programming. Appearances, of course, are not always representative of the energetic thrust of a company. James Pusey, chairman and CEO of Omnicare CR, had previously helped turn around a division of MDS Pharma prior to its sale to Inc Research. Last week Pusey helped to finalize the sale of Omnicare CR to investors at Nautic Partners for an undisclosed sum. He'll continue on as the chief of Omnicare CR, which will eventually be renamed to avoid confusion with its former corporate parent, a nursing home chain. Pusey notes that several big CROs were in the bidding for Omnicare, and that Nautic was chosen partly for…more...
It's a great debate, and far from over. Some analysts predict the large contract research organizations (CRO) will eventually manage the bulk of industry-sponsored research. Others predict that mid-tier and specialty…more...
If you're a clinical research site accepting studies from industry, you've probably seen it. The dreaded cross-indemnification clause. It's an increasingly common element of standard contracts. Under cross indemnification, sites take…more...
Lean sigma. Six sigma. Lean six sigma. They are buzzwords in the pharmaceutical and contract research organization (CRO) industries, with executives tossing around “black belt” and “green belt” references at conference…more...
The software that ordinary people prefer is getting simpler. Easier. And it’s increasingly running not on a desktop computer, like Microsoft Word, but online. Last year, the web ratings firm comScore estimated in this Powerpoint deck that, in the U.S., an impressive 78 percent of users had tried a small, internet program called a widget. Widgets are…more...
Does the pharmaceutical industry need to rethink the management of drug safety data and pharmacovigilance? A few companies already are. That was clear at this year’s annual Society For Clinical Data Management (SCDM) meeting. Appropriately, the session tried to explore the tenuous technological links between two areas of human expertise: the medical interpretation of drug safety issues…more...
It’s hard to compete with 540-plus exhibitor booths for the attention of 8,000-plus people meandering around. Actually, it’s way beyond hard. But a few companies at this year’s Drug Information Association (DIA) conference in Boston managed to captivate us. Chief among them: the standard-sized booth of Coast Independent Review Board (IRB). The Colorado Springs, CO-based IRB hired…more...
Could the pharmaceutical industry manage clinical data more intelligently, using software to go toe to toe with Steve Nissen of the Cleveland Clinic? Would such tools ensure more consistent communications with regulatory bodies? Properly executed, could better software even deflect a meta-analysis cooked up in academia? The answer from SAS is yes. At this year’s annual meeting…more...
The large CRO recently moved its headquarters and went from public to private.
Inspired by Web 2.0 tools that foster sharing and collaboration, Insightful Software released new software to generate charts and graphs in a regulated setting.
Four options for those considering where to put cleaned clinical trial data in the future
A consultant discusses why the industry is using the wrong word for a key part of the clinical trial datascape—and why it matters.
Briefs for June 22nd.
News for June 21.
The leading biostatistical house and a top EDC vendor say they have a better way to move clinical data toward analysis.
Organizations
Conferences
Info & Opinion
© 2012 ClinPage. All Rights Reserved.